Work

Randomized, prospective, placebo‐controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis

Year: 2010

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Arthritis & Rheumatism

DOI: 10.1002/art.27466

Authors: J. R. Seibold, C. P. Denton, D. E. Furst, L. Guillevin, L. J. Rubin, A. Wells, M. Matucci Cerinic, G. Riemekasten, P. Emery, H. Chadha‐Boreham, P. Charef, S. Roux, C. M. Black

Institutions: University of Connecticut, UConn Health, The Royal Free Hospital, University of California, Los Angeles, Hôpital Cochin, University of California San Diego, University of Florence, Charité – Universitätsmedizin Berlin, University of Leeds, Chapel Allerton Hospital, Actelion (Switzerland)

Language: English

Topic: Systemic Sclerosis and Related Diseases

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institute for Health and Care Research, Versus Arthritis, Actelion Pharmaceuticals

Awards: NIHR Senior Investigator Award, G8903934815

OpenAlex ID: W1996935411

FWCI: 8.204

Cites: 32

Cited by: 142

Related to: 10